Abstracts

NON-HIV ENTRY POINTS TO DELIVER HIV SERVICES TO TRANSGENDER WOMEN IN INDIA

Background: Transgender (TG) women in India have a 14 times higher burden of HIV compared to the general population. They also face substantial societal challenges with access to HIV prevention and treatment services. Further, for most transwomen access to hormone replacement therapy (HRT), cosmetology, and social entitlements take precedence over HIV services. Consequently, we established…

HIV GAG X CD3 SOLUBLE TCR BISPECIFIC: SAFETY AND ACTIVITY IN A FIRST IN HUMAN TRIAL

Background: A stable reservoir of replication-competent HIV proviruses that persist in CD4+ T cells is the main barrier to functional cure. Safe and effective strategies for immune clearance of the HIV reservoir are needed. Immune-mobilising monoclonal T cell receptors (TCR) against viruses (ImmTAV®) are unique bispecific soluble proteins comprising an affinity-enhanced TCR fused to an…

INTERACTION BETWEEN TAF-BASED PrEP AND HORMONE THERAPY IN TRANSGENDER WOMEN: iFACT 3

Background: Feminizing hormone therapy (FHT) is common among transgender women (TGW) receiving PrEP. To evaluate the potential drug-drug interaction (DDI) between FHT and emtricitabine (FTC)/tenofovir alafenamide (TAF)-based PrEP, we assessed the pharmacokinetics (PK) of FTC, TAF, tenofovir (TFV) and estradiol (E2) among TGW receiving FHT in Thailand. Methods: Twenty TGW who had not undergone orchiectomy…

ELEVATED HIV VIRAL LOAD IS ASSOCIATED WITH HIGHER VIRAL RECOMBINATION RATE IN VIVO

Background: Intra-host recombination of HIV generates new mutational combinations which enable immune escape and multidrug resistance within people living with HIV (PLWHIV). Because HIV recombines via coinfection, we hypothesize that denser HIV populations may have higher rates of coinfection and therefore recombination. However, this potential impact of viral density on recombination has not been previously…

ISOLATION OF PAN-SARBECOVIRUS mABs THAT NEUTRALIZE SARS-CoV-1 AND SARS-CoV-2 VARIANTS

Background: The continued emergence of severe acute respiratory syndrome coronaviruses (SARS-CoVs) and recent explosion of the SARS-CoV-2 pandemic highlights the need for broad and potent antibody recognition and understanding the contexts in which they may develop. Antibodies with cross reactivity across SARS lineages may be of particular value in preparing for future outbreaks of new…